Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.117
-0.043 (-3.67%)
Dec 11, 2025, 10:39 AM EST - Market open
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $25.03 million as of December 11, 2025. Its market cap has increased by 537.52% in one year.
Market Cap
25.03M
Enterprise Value
21.86M
1-Year Change
537.52%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $25.03M, a decrease of -61.67%. That is a compound annual growth rate of -20.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 25.98M | 551.32% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |